David Hirsch
CIK 1619884 · last filed 2024-05-28
David Hirsch is a corporate insider who has filed 34 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for RPID, was dated May 28, 2024. Across all open-market trades the lifetime net is +$7.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $10.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.19M
6
34
$7.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPID | Director | 3,422,252 | $2.06 | $7.05M | $0 | 5 | 2024-05-28 |
| Tricida, Inc. (TCDA) Delisted | Director | 3,047,318 | $0.11 | $329.1K | $2.50M | 5 | 2022-06-16 |
| Molecular Templates, Inc. (MTEM) Delisted | Director | 213,379 | $0.00 | $21 | $17.00M | 10 | 2022-06-06 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 2,714,245 | $9.50 | $25.79M | $4.00M | 4 | 2021-07-26 |
| COLL | Director | 82,504 | $35.90 | $2.96M | $1.92M | 4 | 2020-05-22 |
| ESPR | Director | 57,325 | $3.18 | $182.3K | -$17.60M | 6 | 2019-09-03 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-28 | RPID | Grant (A) | +14,300 | $0 | EDGAR |
| 2023-05-05 | RPID | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | Tricida, Inc. (TCDA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | RPID | Grant (A) | — | $0 | EDGAR |
| 2022-06-06 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-26 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-20 | RPID | Conv (C) | +3,344,038 | $0 | EDGAR |
| 2021-07-15 | RPID | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Tricida, Inc. (TCDA) Delisted | Grant (A) | +16,403 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.